1Life Healthcare (NASDAQ:ONEM) Receives New Coverage from Analysts at Stifel Nicolaus

Research analysts at Stifel Nicolaus assumed coverage on shares of 1Life Healthcare (NASDAQ:ONEMGet Rating) in a research note issued to investors on Thursday, The Fly reports. The brokerage set a “buy” rating on the stock.

ONEM has been the topic of several other research reports. Guggenheim started coverage on 1Life Healthcare in a report on Tuesday, March 29th. They set a “neutral” rating on the stock. William Blair reaffirmed an “outperform” rating on shares of 1Life Healthcare in a report on Thursday, March 10th. Canaccord Genuity Group cut their target price on 1Life Healthcare from $18.00 to $14.00 and set a “buy” rating on the stock in a report on Thursday, May 5th. KeyCorp cut their target price on 1Life Healthcare from $30.00 to $14.00 and set an “overweight” rating on the stock in a report on Thursday, February 24th. Finally, Truist Financial cut their target price on 1Life Healthcare from $24.00 to $12.00 in a report on Thursday, February 24th. Four analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $19.25.

Shares of NASDAQ ONEM traded up $0.15 during mid-day trading on Thursday, hitting $8.45. 178,627 shares of the stock traded hands, compared to its average volume of 2,621,187. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.64 and a quick ratio of 2.61. 1Life Healthcare has a twelve month low of $5.94 and a twelve month high of $38.16. The company has a market cap of $1.64 billion, a PE ratio of -4.75 and a beta of 1.87. The firm has a 50 day simple moving average of $9.25 and a two-hundred day simple moving average of $12.47.

1Life Healthcare (NASDAQ:ONEMGet Rating) last released its quarterly earnings data on Wednesday, May 4th. The company reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($0.49) by $0.02. 1Life Healthcare had a negative return on equity of 21.62% and a negative net margin of 40.50%. The company had revenue of $254.10 million for the quarter, compared to the consensus estimate of $246.57 million. During the same quarter last year, the business posted ($0.29) EPS. 1Life Healthcare’s revenue for the quarter was up 109.4% on a year-over-year basis. On average, equities research analysts anticipate that 1Life Healthcare will post -1.85 earnings per share for the current fiscal year.

Hedge funds have recently modified their holdings of the business. Nikko Asset Management Americas Inc. raised its holdings in 1Life Healthcare by 12.1% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 774,516 shares of the company’s stock valued at $12,415,000 after acquiring an additional 83,760 shares during the period. WCM Investment Management LLC raised its holdings in 1Life Healthcare by 5.6% during the 4th quarter. WCM Investment Management LLC now owns 393,412 shares of the company’s stock valued at $6,912,000 after acquiring an additional 20,778 shares during the period. Renaissance Technologies LLC raised its holdings in 1Life Healthcare by 43.9% during the 3rd quarter. Renaissance Technologies LLC now owns 1,074,900 shares of the company’s stock valued at $21,767,000 after acquiring an additional 327,700 shares during the period. Franklin Resources Inc. raised its holdings in 1Life Healthcare by 36.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,586,748 shares of the company’s stock valued at $32,132,000 after acquiring an additional 421,624 shares during the period. Finally, Must Asset Management Inc. raised its holdings in 1Life Healthcare by 17.4% during the 4th quarter. Must Asset Management Inc. now owns 131,737 shares of the company’s stock valued at $2,287,000 after acquiring an additional 19,504 shares during the period. 85.50% of the stock is currently owned by institutional investors and hedge funds.

1Life Healthcare Company Profile (Get Rating)

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.

See Also

The Fly logo

Analyst Recommendations for 1Life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.